Guozhang Xu

This inventor holds 31 USPTO granted patents and 22 published patent applications, plus 1 CIPO patent and 9 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Janssen Pharmaceutica Nv, Johnson & Johnson Pharmaceuticals Research & Development, L.l.c.. Active years: 2009-2026.

USPTO Granted Patents = 31 (Patent Applications = 22)

% Patents Active = 45.2

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 9 (Patent Applications = 11)

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 21(Granted Patents)

Location History:

Langhorne, PA (US) (2009)
Bensalem, PA (US) (2010 - 2015)
Chesterbrook, PA (US) (2018 - 2024)

Company Filing History:

30 out of 2,099

Janssen Pharmaceutica Nv

patents

1 out of 1

Johnson & Johnson Pharmaceuticals Research & Development, L.l.c.

patent

Years Active: 2009-2026

Loading Chart...

Areas of Expertise:

Factor XIa Inhibitors

Glucagon Receptor Antagonists

SGLT1 Modulators

SGLT2 Modulators

Thiazolidinedione Indazoles

Phenoxy Thiazolidinediones

Pyridine N-Oxide Derivatives

Kinase Inhibitors

Aminothiazolones

Indazole Derivatives

Bicyclic Pyridine

Alkylquinoline

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12545677 - Compounds useful as factor XIa inhibitors (2026-02-10),

2. 12286429 - 5-oxo-1,2,3,5,8,8a-hexahydroindolizine-3-carboxamide derivatives useful as a factor XIa inhibitors (2025-04-29),

3. 11958856 - Substituted 1,2,3,8,9,9a-hexahydro-5H-pyrrolo[1,2-a]azepin-5-ones as factor XIa inhibitors (2024-04-16),

4. 11919881 - Substituted pyridine N-oxide derivatives useful as a factor XIa inhibitors (2024-03-05),

5. 11897880 - 7,8-dihydrobenzo[e]pyrido[3,4-c]azocine-2,5(3H,6H)-dione derivatives useful as a factor XIa inhibitors (2024-02-13),

6. 11845748 - Bicyclic pyridine N-oxide derivatives useful as a factor XIa inhibitors (2023-12-19),

7. 11814364 - Pyridine N-oxide derivatives useful as factor XIa inhibitors (2023-11-14),

8. 11098016 - Indazole derivatives useful as glucagon receptor antagonists (2021-08-24),

9. 11014917 - 5-fluoro-c-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators (2021-05-25),

10. 10815210 - Benzocyclobutane derivatives useful as dual SGLT1 / SGLT2 modulators (2020-10-27),

11. 10774048 - Indazole derivatives useful as glucagon receptor antagonists (2020-09-15),

12. 10696662 - 5-fluoro-C-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators (2020-06-30),

13. 10251864 - Indole derivatives useful as glucagon receptor antagonists (2019-04-09),

14. 10214493 - Indazole derivatives useful as glucagon receptor antagonists (2019-02-26),

15. 10000473 - Indazole derivatives useful as glucagon receptor antagonists (2018-06-19),

Title: The Innovative Journey of Guozhang Xu

Introduction: Guozhang Xu, a talented inventor based in Bensalem, PA (US), has made significant contributions to the field of technology with his groundbreaking inventions.

Latest Patents: Guozhang Xu's latest patents include a cutting-edge software application for data encryption and a revolutionary device for enhancing solar energy efficiency.

Career Highlights: With over two decades of experience in the tech industry, Guozhang Xu has a proven track record of developing innovative solutions. He has worked for leading tech companies and research institutions, honing his skills and pushing the boundaries of technology.

Collaborations: Guozhang Xu has collaborated with top engineers, scientists, and researchers from renowned universities and tech companies worldwide. His collaborative projects have resulted in pioneering inventions that have shaped the tech landscape.

Conclusion: Guozhang Xu's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors. His dedication to pushing the boundaries of what is possible in the tech industry makes him a true visionary in the field of inventions.